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Abstract
Background:  Bronchiectasis  can  result  from  many  diseases,  which  makes  the  aetiological  inves-
tigation a  complex  process  demanding  special  resources  and  experience.  The  aetiological
diagnosis  has  been  proven  to  be  useful  for  the  therapeutic  approach.
Objective:  Evaluate  how  accurately  and  extensive  the  clinical  and  aetiological  research  was
for adult  bronchiectasis  patients  in  pulmonology  outpatient  service  which  were  not  following  a
pre-existing  protocol.
Methods:  We  retrospectively  reviewed  the  records  of  202  adult  patients  with  bronchiectasis,
including the  examinations  performed  to  explain  the  aetiology.
Results:  The  mean  age  of  the  patients  was  54  ±  15  years,  there  was  a  predominance  of  female
(63.9%) and  non-smoker  (70%)  patients.  Functional  evaluation  showed  a  mild  airway  obstruction.
The sputum  microbiological  examination  was  available  for  168  patients  (43.1%  had  3  or  more
sputum examinations  during  one  year).  Immunoglobulins  and  1-antitrypsin  were  measured  in
around 50%  of  the  patients.  The  sweat  test  and  the  CF  genotyping  test  were  performed  in  18%
and 17%  of  the  patients,  respectively.The most  commonly  identiﬁed  cause  was  post-infectious  (30.3%),  mostly  tuberculosis  (27.2%).
No deﬁnitive  aetiological  diagnosis  was  established  in  57.4%  of  the  patients.  We  achieved  a  lower
aetiological  diagnosis  if  we  compare  our  series  with  studies  in  which  a  diagnostic  algorithm  was
applied prospectively.
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Conclusions:  The  general  characteristics  of  our  patients  were  similar  with  other  series.  Detailed
investigation  of  bronchiectasis  is  not  a  standard  practice  in  our  outpatient  service.  These  results
suggest that  the  use  of  a  predeﬁned  protocol,  based  on  current  guidelines,  could  improve  the
assessment  of  these  patients  and  facilitate  the  achievement  of  a  deﬁnitive  aetiology.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
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ronchiectasis  (BE)  results  from  a  large  number  of  diseases
nd  is  associated  with  high  morbidity  and  signiﬁcant  costs
or  health-care  systems.1,2
For  many  years  respiratory  infections  were  the  main
dentiﬁable  cause.  However,  post-infectious  BE  has  been
ecreasing  mainly  in  developed  countries  due  to  vaccination
rogrammes,  antibiotic  therapy  and  better  social-hygienic
onditions  while  other  congenital  or  acquired  causes  have
een  described  now  that  we  have  more  accurate  diagnosis
ethods.3
In  recent  years,  a  number  of  studies  have  shown  that  an
etiological  diagnosis  can  change  the  therapeutic  approach
n  a  relevant  percentage  of  patients.4--6
Research  carried  out  in  units  with  great  experience  in
E  and  with  specialized  resources  may  not  be  typical  of  the
ssessment  which  is  carried  out  in  the  majority  of  general
espiratory  services.  There  is  some  evidence  that  the  study
nd  follow-up  of  patients  in  specialized  centres  probably
ontribute  to  a  larger  number  of  aetiological  diagnoses  and
ore  appropriate  treatment.5,6
The  local  characteristics  of  BE  patients  were  unknown,
amely  the  level  of  research,  BE  aetiologies,  functional
everity  and  microbiological  characteristics.
The  aim  of  this  study  was  to  evaluate  how  accurate  and
xtensive  the  clinical  and  aetiological  research  was  for  BE
atients  followed  in  the  pulmonology  outpatient  service  of
 central  hospital  which  did  not  routinely  use  a  thorough,
re-existing  protocol  for  it.
aterials and methods
 retrospective  analysis  of  the  clinical  records  of  adult
atients  with  BE  diagnosis  who  were  seen  and  managed  in
he  pulmonology  outpatient  service,  from  January  2008  to
anuary  2009,  was  carried  out.  The  patients  concerned  had
o  be  followed-up  for  at  least  1  year.
The  diagnosis  of  BE  was  established  by  the  character-
stic  features  of  the  high-resolution  computed  tomography
HRCT)  of  the  thorax  (bronchoarterial  ratio  ≥1,  dilated
ronchi  visible  ≤1  cm  from  parietal  pleura,  cystic  changes
nd  a  lack  of  normal  bronchial  tapering)  or  the  CT,  if
nequivocal  evidence  of  BE  existed.
Patients  with  CF  and  interstitial  pathology  were
xcluded.Each  pulmonologist  involved  was  totally  responsible  for
he  clinical  records,  the  follow-up  and  aetiological  research,
ithout  having  to  comply  with  any  predeﬁned  protocol.  We
rrived  at  an  aetiological  diagnosis  based  on  the  clinical
B
o
lecords  and  the  results  of  earlier  diagnostic  tests  done  by
he  patient’s  clinician.  There  was  no  subsequent  research
one  to  complement  our  study.
The  demographical,  clinical,  functional,  radiological  and
icrobiological  data  were  reviewed.  The  exams  that  had
een  performed  to  explain  the  BE  aetiology,  namely,  the
weat  test,  cystic  ﬁbrosis  (CF)  genotyping,  measurement  of
erum  immunoglobulins  (Igs),  1-antitrypsin  (AAT)  and  the
emen  analysis  were  recorded.
The  sweat  test  was  performed  by  conductivity  method
nd  the  CF  genotyping  test  screened  the  33  most  frequent
FTR  mutations  in  Portuguese  population.  In  some  cases  a
omplete  analysis  of  the  CFTR  gene  was  performed.
The  respiratory  function  tests  were  done  according  to
tandard  international  recommendations.7
The  isolation  of  the  same  pathogen  in  at  least  3  sputum
amples,  for  at  least  one  year  and  with  a  minimal  interval  of
ne  month,  was  considered  by  the  authors  as  the  deﬁnition
f  chronic  airway  colonization.
Statistical  analysis  was  done  with  SPSS  19,  2010  soft-
are  program  (Statistical  Package  for  Social  Sciences,
PSS  Inc.,  Chicago,  IL,  USA).  Descriptive  statistics  (mean,
tandard  deviation)  were  used  to  summarize  the  data.  The
olmogorov--Sminorv  test  was  used  to  analyze  the  distribu-
ion  of  variables.  Variables  with  a  normal  distribution  were
nalyzed  using  the  student  t-test,  while  in  the  abnormal
nes  the  Mann--Whitney  U  test  was  employed.  The  signiﬁ-
ance  level  was  set  at  p  <  0.05.
The  project  was  approved  by  the  Ethics  Committee  for
ocal  Health  of  the  CHSJ.
esults
he  clinical  records  of  202  patients  with  BE  diagnosis  were
eviewed.
The  diagnosis  was  established  by  HRCT  in  94%  of  the
atients  and  by  CT  scan  in  the  remaining  patients.
The  patients’  general  characteristics  are  shown  in
able  1.
Fertility  information  was  missing  for  40  (54.7%)  of  the
ale  patients.  The  upper  airway  symptoms  were  also  rarely
entioned,  as  well  as,  occupational  exposure  to  toxic  chem-
cals,  family  history  of  BE,  non  respiratory  symptoms  and
onsanguinity  data.
adiologyE  had  a  bilateral  distribution  in  89%  of  the  patients.  In  6%
f  the  cases  only  1  lobe  was  affected  and  in  80.4%  4  or  more
obes  were  affected  or  there  were  cystic  changes  in  2  or
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Table  1  General  characteristics.
Characteristics
Sex  n  (%)
Female  129  (63.9)
Age,  years  (mean  ±  SD),
n  =  202
54.4  ±  15.8
Diagnosis  age
(mean  ±  SD),  n  =  167
47.4  ±  17
Follow  up,  years
(mean  ±  SD),  n  =  202
5.61  ±  7.1
Years elapsed  from
symptoms  onset  and
diagnosis  (mean  ±  SD),
n =  133
16.9  ±  15
Smoking  habits,  n  =  169  (%)
Non-smokers  119  (70.4)
Smokers  19  (11.2)
Ex-smokers  31  (18.3)
Sputum, n  =  187  (%)
Daily  110  (58.8)
Purulent/mucopurulent  83  (75.5)
Exacerbations  77  (41.2)
Dyspnea, n  =  176  (%)  74.4
Table  2  Chronic  airway  colonization.
Microbiological  agent  n  =  43  (%)
Pseudomonas  aeruginosa  32  (74.4)
Haemophilus  inﬂuenzae 3  (7)
Achromobacter  xylosoxidans 2  (4.7)
P. aeruginosa  +  Proteus  mirabilis  1
P. aeruginosa  +  Haemophilus  inﬂuenzae  1
P. aeruginosa  +  MRSA  1
Streptococcus  pneumoniae  1
Enterobacter  cloacae  1
Aspergillus  fumigatus  1
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of  the  cases,  and  1  patient  was  found  to  have  1  mutation
(R334W).  The  extensive  genetic  test  was  performed  in  4.9%
of  the  patients.  One  mutation  (V754M)  was  detected  in  1  of
A fumigatus precipitins
A fumigatus IgG
A fumigatus IgE
IgE total
IgM
IgA
IgG subclasses
Total IgG
CF genetic analysis
2 sweat tests
1 sweat test
AAT
0% 10% 20% 30% 40% 50% 60%Hemoptysis, n  =  202  (%)  61  (30.2)
more  lobes.  The  predominant  morphology  was  cylindrical
(47%),  followed  by  cylindrical  associated  with  cystic  (34%).
The  lower  lobes  (LL)  were  the  most  frequently  affected
(right  LL  in  88%  and  left  LL  in  86%).
Microbiology
Thirty-four  patients  (16.8%)  did  not  have  a  record  of  a  spu-
tum  microbiological  examination.
Out  of  168  patients  with  at  least  one  sputum  microbio-
logical  examination,  the  most  frequently  isolated  bacteria
once  or  intermittently  was  Haemophilus  inﬂuenzae  (26.8%),
followed  by  Streptococcus  pneumoniae  (16.7%)  and  Pseu-
domonas  aeruginosa  (14.9%).
Eighty-seven  patients  (43.1%)  had  done  3  or  more  spu-
tum  examinations  during  the  period  of  one  year,  of  which
43  (49.4%)  met  the  chronic  colonization  criteria.  The  most
commonly  isolated  bacteria  in  this  set  of  patients  was  P.
aeruginosa  (81.4%),  associated  in  3  cases  with  other  bacte-
ria,  followed  by  H.  inﬂuenzae  (9.1%)  and  Achromobacter
xylosoxidans  (4.7%)  (Table  2).
Atypical  mycobacteria  were  identiﬁed  in  20  patients,  cor-
responding  to  23  different  isolations,  as  2  different  species
were  isolated  in  3  patients  on  different  occasions.  The
species  belonging  to  Mycobacterium  avium-complex  (MAC)
were  the  most  common  (65.2%),  followed  by  M.  kansasii
(17.4%),  M.  gordonae  (8.7%),  M.  fortuitum  (4.3%)  and  M.
peregrinum  (4.3%).  In  most  cases  (60.9%)  only  one  positive
culture  was  identiﬁed.  Ten  patients  underwent  treatment,
9  for  MAC  and  1  for  M.  Kansasii  infection,  of  which  2  did  not
meet  the  nontuberculosis  mycobacterial  infection  published
criteria.8MRSA, methicilin-resistant Staphylococcus aureus.
After  the  BE  diagnosis,  5  patients  had  pulmonary  tuber-
ulosis  (PT).
espiratory  function
he  results  of  the  functional  assessments,  based  on  the  most
ecent  records,  are  presented  in  Table  2. Overall,  the  FEV1
as  65%  of  predicted,  of  which  32%  had  FEV1  <50%,  31%  had
etween  50  and  70%  and  37%  reached  >70%.
Thirteen  percent  of  the  patients  had  type  II  and  5%  type
 respiratory  failure.
In  a  comparative  analysis  of  pulmonary  function  of
hronic  and  non-chronic  colonized  patients  the  ﬁgures
Table  3)  showed  statistically  signiﬁcant  lower  values  of
VC,  FEV1,  FEV1/FVC  ratio  and  RV  in  colonized  patients.
he  differences  between  the  TLC  did  not  reach  statistical
igniﬁcance.
etiological  investigation
he  exams  carried  out  to  investigate  the  BE  aetiology  are
hown  in  Fig.  1.
The  CF  genetic  analysis  was  performed  in  34  (16.8%)BE of unknown cause Total of patients
Figure  1  Aetiological  investigation.  AAT,  1-antitrypsin.
8  A.  Amorim  et  al.
Table  3  Pulmonary  function.
Parameter  Total  (n  =  195)  Chronic  colonized  (n  =  43)  Non-chronic  colonized  (n  =  152)  p  value
(liters), mean  and  SD
% of  predicted  and  SD
(liters),  mean  and  SD
% of  predicted  and  SD
(liters),  mean  and  SD
% of  predicted  and  SD
FVCa 2.51  ±  0.87  1.94  ±  0.75  2.67  ±  0.84  <0.01
84.9 ±  23.5  69.5  ±  22  89.4  ±  22.1  <0.01
FEV1b 1.78  ±  2.7  1.12  ±  0.48  1.74  ±  0.75  <0.01
65.1 ±  25.4  48.4  ±  16.2  70.1  ±  25.3  <0.01
FEV1/FVC 63  ±  14.3  58.8  ±  11.2  64.3  ±  14.7  <0.01
TLCc 5.02  ±  1.2  4.73  ±  1.2  5.08  ±  1.2  nse(0.121)
101.4 ±  19.2 98.3  ±  22 102  ±  18.3 ns  (0.219)
RVd 2.48  ±  0.9 2.6  ±  0.93 2.41  ±  2.67 0.033
137.2 ±  49.4 153.9  ±  62 132  ±  153.9 0.012
a Forced vital capacity.
b Forced expiratory volume in 1 s.
c Total lung capacity.
d Residual volume.
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he  patients  and  2  mutations  [G576A;  R668C]  were  detected
n  another  patient  which  after  family  screening  was  con-
rmed  to  be  in  cis.  The  sweat  test  in  these  patients  was
egative.
Five  patients  did  a  semen  analysis,  and  infertility  was
onﬁrmed  in  3  cases  (one  was  diagnosed  as  PCD  and  the
ther  two  were  considered  as  of  unknown  cause).
In  relation  to  the  upper  airways,  45  patients  (22.3%)  did
asal  CT  and  ﬁndings  were  suggestive  of  chronic  sinusitis  in
4  (11.9%).
The  aetiologies  shown  in  Table  4  were  based  on  the  clin-
cal  records  and  the  results  of  the  exams  carried  out.  A
eﬁnitive  aetiological  diagnosis  was  not  established  in  57.4%
f  the  patients.  In  30.3%  BE  was  post-infectious,  mostly  sec-
ndary  to  tuberculosis  (27.2%).
The  7  cases  of  immunodeﬁciency  include  2  IgA  deﬁ-
iencies  (with  IgG4  deﬁciency),  3  common  variable
mmunodeﬁciencies  and  2  hematologic  malignancies.
iscussion
he  202  patients  in  the  study  were  followed  in  the  pul-
onology  outpatient  service.  There  was  a  predominance  of
emale  and  non-smoker  patients  in  the  evaluated  popula-
ion,  which  is  consistent  with  most  published  series.9,10
There  was  a  long  delay  in  diagnosis.  This  could  be  due
o  the  lack  of  speciﬁcity  of  BE  symptoms  which,  on  many
ccasions,  can  lead  to  a  misdiagnosis  of  COPD  or  asthma11,12
ith  prognostic  implications.4,5,13
The  patient  information  was  recorded  and  follow-ups  car-
ied  out  without  a  predeﬁned  protocol,  based  on  existing
uidelines,  which  certainly  contributed  to  the  absence  of
mportant  clinical  historic  data,  subjective  descriptions  of
ome  symptoms  and  the  lack  of  appropriate  investigation
ests.
The  result  of  the  functional  assessment  was  compat-
ble  with  an  obstructive  pattern,  as  described  in  the
iterature.14,15
s
m
iThe  HRCT  is  considered  the  gold  standard  diagnostic  test
or  BE  and  in  this  review  it  was  chosen  as  the  conﬁrma-
ory  diagnostic  method.  In  most  cases  BE  was  bilateral  and
he  predominant  morphology  was  cylindrical,  followed  by
ylindrical  in  association  with  cystic.  This  result  is  partly  a
onsequence  of  a  more  generalized  use  of  HRCT  and  its  high
ensitivity.16,17
According  to  current  recommendations,  sputum  culture
hould  be  carried  out  regularly.10,18 It  was  not  quite  clear
hy  115  (56.9%)  patients  had  not  had  one  or  had  fewer  than
 samples  per  year.  This  may  have  led  to  an  underestimation
f  the  real  number  of  chronic  colonizations.  The  bacteria
ost  commonly  isolated,  intermittently  or  only  once,  was
.  inﬂuenzae  and  the  bacteria  most  frequently  associated
ith  chronic  colonization  was  P.  aeruginosa. The  presence
f  the  latter  has  been  linked  to  greater  clinical  and  func-
ional  severity,  greater  numbers  of  exacerbations  and  worse
uality  of  life.2,19 This  fact  could  explain  why  further  bac-
eriological  sputum  tests  had  been  requested  for  this  subset
f  patients,  which  means  that  P.  aeruginosa  may  not  be  the
acteria  most  frequently  associated  with  chronic  coloniza-
ion.
The  pulmonary  function  was  signiﬁcantly  worse  in  the
hronic  colonized  patients,  which  reﬂects  the  severity  usu-
lly  associated  with  the  chronic  infection.
The  prevalence  of  mycobacteria  in  BE  patients  is  rela-
ively  low,  ranging  between  2%  and  10%.20,21 In  this  series  the
revalence  was  in  this  range,  MAC  being  the  most  common.22
The  assessment  of  BE  patients  must  always  include  the
nvestigation  of  the  primary  cause.10,18,23
Fig.  1  shows  the  diagnostic  tests  carried  out  in  total
atients  and  in  the  cases  of  BE  of  unknown  cause.  The  per-
entage  of  tests  done  is  similar  between  the  two  groups,
hich  suggests  that  further  research  could  be  done,  using
ur  local  resources.
According  to  current  recommendations,  a  conductivity
weat  test  value  >60  mmol/l  should  be  conﬁrmed  by  chloride
easurement24; this  is  not  available  in  our  hospital.
The  CF  genetic  test  allowed  the  detection  of  mutations
n  3  patients  who  were  considered  to  have  a  CFTR-related
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Table  4  Aetiological  diagnosis  and  comparison  with  prospective  studies.
Aetiology  Amorim
et  al.
(n =  202)  %
Pasteur
et  al.4
(n  =  150)  %
Shoemark
et  al.5
(n  =  165)  %
McShane
et  al.8
(n  =  106)  %
Unknown/idiopathic  116  (57.4)  80  (53)  43  (26)  7  (6.6)
Pos-infection  (PTa and  others)  62  (30.3)  44  (29)  54  (32.8)  10  (9.4)
Primary ciliary  dyskinesia  1  (<1)e 3  (1.5)  17  (10)  3  (2.8)
ABPAb 1  (<1)  11  (7)  13  (8)  1  (0.9)
Immunodeﬁciency  7  (3.5)  12  (8)  11  (7)  33  (31.1)
Intestinal inﬂammatory  disease  1  (<1)  2  (<1)  5  (3)  2  (2.8)
1-Antitrypsin  deﬁciency 3  (1.4) 0  0  12  (11.3)
Young’s syndrome 0  5  (3) 5  (3) 0
Panbronchiolitis 0  1  (1) 4  (2) 0
Yellow nail  syndrome  0  0  4  (2)  0
Nodular bronchiectatic  disease  2  (<1)  0  2  (1.2)  10  (9.4)
Autoimmune  disease  3  (1.4)f 4  (3)f 3  (2)f 30  (28.3)
Aspiration 2  (<1)  6  (4)  2  (1)  12  (11.3)
CFc/CFRDd 3  (1.4)  4  (3)  2  (1)  0
Congenital anatomical  defects  1  (<1)g 1  (<1)  0  1  (0.9)h
Others  3
a Pulmonary tuberculosis.
b Allergic bronchopulmonary aspergillosis.
c Cystic ﬁbrosis.
d Cystic ﬁbrosis related disease.
e Diagnosis not based on gold standard exams.
f Rheumatoid arthritis.
g Bronchial atresia.
h
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animals  for  this  study.Mounier--Kuhn syndrome.
disorder  because  the  sweat  test  was  negative  and  only  one
mutation  or  two  mutations  in  cis  were  detected.25,26 How-
ever,  to  exclude  CF  with  accuracy  the  quantitative  sweat
test  should  have  been  carried  out  on  these  patients  and,  if
necessary,  the  nasal  potential  difference,  which  is  not  done
in  our  country.
In  this  review,  an  aetiological  diagnosis  was  obtained  in
42.1%  (Table  4)  and  the  post-infectious  cause  was  the  most
common,  like  other  published  series.2,14,27 Compared  with
studies  in  which  a  diagnostic  algorithm  was  applied  prospec-
tively  (Table  4)  our  result  is  lower.4,5,28
COPD  was  not  considered  as  a  cause  of  BE,  despite
the  fact  that  some  studies  have  shown  an  unexpectedly
high  incidence  of  BE  in  this  disease.28--31 In  light  of  current
knowledge,10 BE  associated  with  COPD  should  only  be  estab-
lished  after  a  careful  aetiological  work-up  to  exclude  other
associated  diseases.
The  reduced  percentage  or  even  absence  of  some
pathologies  in  our  study,  namely  ABPA,  immunodeﬁciency
and  PCD4--6 suggest  that  the  implementation  of  an  algo-
rithmic  investigation  and  the  availability  of  speciﬁc  tests
could  facilitate  the  achievement  of  rare  and/or  complex
diagnosis.
ConclusionIn  the  recent  years  there  has  been  a  resurgence  of  interest
in  BE  and  it  is  urgent  to  set  out  our  practice  in  the  latest
existing  guidelines  and  to  review  our  standards  of  care.
C
f
tIn  our  country  there  are  no  specialized  centres  for  BE;
ot  even  in  central  hospitals.
As  BE  can  result  from  several  diseases,  a  detailed  clinical
istory  and  physical  examination  is  fundamental  in  order  to
stablish  the  diagnostic  hypothesis  and  to  guide  the  research
n  the  most  appropriate  way.
Our  results  show  how  important,  useful  clinical  and  aetio-
ogical  ﬁndings  could  be  missed  when  a  pre-existing  protocol
s  not  being  used.  If  the  investigation  and  medical  follow-
ps  were  done  with  a  pre-deﬁned  protocol  based  on  current
ublished  guidelines,10,18 we  would  probably  have  a  higher
ercentage  of  accurate  diagnoses  and  a  better  clinical  char-
cterization  of  the  patients.
The  establishment  of  dedicated  outpatient  clinics  may
elp  to  improve  the  global  management  of  these  patients,
rom  diagnosis  to  therapeutic  interventions,  and  conse-
uently  improve  prognosis  and  understanding  of  the  natural
ourse  of  the  disease.
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